US Stock MarketDetailed Quotes

TNDM Tandem Diabetes Care

Watchlist
  • 35.910
  • +2.640+7.94%
Close Dec 20 16:00 ET
  • 35.910
  • 0.0000.00%
Post 20:05 ET
2.36BMarket Cap-18.51P/E (TTM)

Tandem Diabetes Care Key Stats

Tandem Diabetes Care Q3 2024 Earnings Date

Currency:USDNov 6, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
224.12M
243.97M
+19.85M
Beat Est.
+20.74%
+31.43%
+8.86%
EPS
-0.42
-0.35
+0.07
Beat Est.
+17.83%
+31.37%
+16.47%
Strong Buy

Dec 11, 2024

Tandem Diabetes Care Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 221.721M--
--2024/Q4-- / 251.390M--
Nov 6, 20242024/Q3243.971M / 224.123M--
Aug 1, 20242024/Q2221.910M / 205.871M--
May 2, 20242024/Q1191.674M / 173.537M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 221.721M--
--2024/Q4-- / 251.390M--
Nov 6, 20242024/Q3243.971M / 224.123M--
Aug 1, 20242024/Q2221.910M / 205.871M--
May 2, 20242024/Q1191.674M / 173.537M--

Unlock Free Earnings Estimates

Tandem Diabetes Care Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 11, 2024

Strong Buy

  • Buy

    78.57%
  • Hold

    21.43%
  • Sell

    0.00%

Price Target

No Data